Addressing organ shortages: progress in donation after circulatory death for liver transplantation
- PMID: 32195556
- PMCID: PMC7828961
- DOI: 10.1503/cjs.005519
Addressing organ shortages: progress in donation after circulatory death for liver transplantation
Abstract
Reducing wait list mortality among patients awaiting liver transplantation remains a substantial challenge because of organ shortage. In efforts to expand the donor pool there has been a trend toward increased use of donation after circulatory death (DCD) liver grafts. However, these marginal grafts are prone to higher complication rates, particularly biliary complications. In addition, many procured DCD livers are then deemed unsuitable for transplant. Despite these limitations, DCD grafts represent an important resource to address the current organ shortage, and as such there are research efforts directed toward improving the use of and outcomes for transplantation of these grafts. We review the current progress in DCD liver transplantation.
La réduction du nombre de personnes en attente d’une greffe de foie qui décèdent avant la transplantation demeure un défi important en raison de la pénurie d’organes. On remarque actuellement une tendance à la hausse dans l’utilisation de greffons de foie provenant de don après décès circulatoire (DDC) dans le but d’élargir le bassin de donneurs. Ces greffons marginaux sont toutefois associés à des taux de complications plus élevés, particulièrement pour ce qui est des complications biliaires. De plus, de nombreux foies obtenus à la suite d’un DDC sont jugés inadmissibles à la greffe. Malgré ces restrictions, les greffons provenant de DDC représentent une importante ressource pour atténuer la pénurie d’organes. Des initiatives de recherche sont donc actuellement en cours dans le but d’améliorer leur taux d’utilisation et les issues des transplantations. Nous analysons ici l’état actuel des progrès pour les transplantations de foie provenant de DDC.
© 2020 Joule Inc. or its licensors
Conflict of interest statement
D. Freed is a co-founder of Tevosol Inc. Tevosol had no input in the design, review or writing of this paper. No other competing interests were declared.
References
-
- Canadian Institute for Health Information. Canadian Organ Replacement Register, 2017 Cumulative Report. Ottawa: CIHI; 2018. [accessed 2019 Jan. 9]. Available: https://www.cihi.ca/en/e-statistics-on-organ-transplants-waiting-lists-a....
-
- Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011;253:259–64. - PubMed
-
- Tang JX, Na N, Li JJ, et al. Outcomes of controlled donation after cardiac death compared with donation after brain death in liver transplantation: a systematic review and meta-analysis. Transplant Proc. 2018;50:33–41. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical